10-Q: Goodness Growth Holdings Reports Q1 2024 Results, Revenue Up 26% Amidst Ongoing Legal and Financial Challenges
Quarterly Report
Goodness Growth Holdings saw a 26% increase in revenue in Q1 2024, driven by Maryland's adult-use cannabis market, while navigating legal disputes and financial uncertainties.
Summary
- Goodness Growth Holdings reported a 26% increase in revenue for the first quarter of 2024, reaching $24.1 million, compared to $19.1 million in the same period last year.
- The revenue growth was primarily driven by the commencement of adult-use sales in Maryland, which contributed significantly to both retail and wholesale revenue increases.
- Retail revenue increased by 19% to $19.6 million, while wholesale revenue surged by 72% to $4.5 million.
- The company's gross profit margin remained relatively stable at 51%, compared to 50% in the prior year.
- Operating income before other expenses and income taxes was $4.8 million, a significant increase from $0.4 million in the same quarter of 2023.
- The company reported a net loss of $6.7 million, or $0.05 per share, compared to a net loss of $8.4 million, or $0.07 per share, in the first quarter of 2023.
- EBITDA, a non-GAAP measure, was $6.8 million, compared to $1.4 million in the prior year.
- The company is facing substantial doubt about its ability to continue as a going concern due to the termination of the Verano merger agreement.
- Management is exploring options such as asset sales, debt restructuring, and capital raises to mitigate these concerns.
- The company is also involved in ongoing litigation with Verano, seeking $869 million in damages for breach of contract.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While revenue growth and improved operating income are positive, the going concern issues, legal challenges, and debt levels create significant uncertainty and risk. The sentiment is therefore cautiously negative.
Positives
- The company experienced a significant increase in revenue, driven by the Maryland market.
- Gross profit margins remained stable year-over-year.
- Operating income showed a substantial improvement.
- EBITDA increased significantly compared to the same period last year.
- The company is actively pursuing legal action against Verano for breach of contract.
Negatives
- The company reported a net loss of $6.7 million for the quarter.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company is facing ongoing litigation with Verano.
- The company is carrying a significant amount of debt.
- The company is exploring asset sales, debt restructuring, and capital raises which may dilute existing shareholders.
Risks
- The termination of the Verano merger agreement has created significant financial uncertainty.
- The ongoing litigation with Verano could have an unpredictable outcome and consume significant resources.
- The company's ability to continue as a going concern is dependent on its future profitability and the success of its mitigation plan.
- The company is subject to regulatory risks associated with the cannabis industry, including potential changes in state and federal laws.
- The company faces competition in the cannabis market, which could put downward pressure on prices and margins.
- The company has a significant amount of debt which may be difficult to service.
Future Outlook
The company's future is uncertain due to the termination of the Verano merger agreement and ongoing litigation. Management is exploring options such as asset sales, debt restructuring, and capital raises to mitigate these concerns. The company's ability to continue as a going concern is dependent on its future profitability and the success of its mitigation plan.
Management Comments
- Company management is working with the Company's lenders, counsel, and other applicable parties to implement a plan to effectively mitigate the conditions giving rise to substantial doubt.
- Elements of this plan may include, but are not limited to, asset sales, debt restructuring, and capital raises.
- The Company believes that Verano has no factual or legal basis to justify or support its purported grounds for termination of the Arrangement Agreement.
- The Company is seeking substantial damages, specifically US $869.0 million, as well as other costs and legal fees, based on Veranos breach of contract and of its duty of good faith and honest performance.
Industry Context
The cannabis industry is experiencing rapid growth and regulatory changes. Goodness Growth's performance is influenced by the evolving legal landscape, particularly the commencement of adult-use sales in Maryland. The company's challenges highlight the risks and uncertainties associated with operating in a federally illegal industry, while also demonstrating the potential for growth in states with favorable regulations.
Comparison to Industry Standards
- Goodness Growth's revenue growth of 26% is a positive sign, but it is important to compare this to other multi-state operators (MSOs) in the cannabis industry.
- Companies like Curaleaf, Trulieve, and Green Thumb Industries, which are larger MSOs, have reported varying growth rates, with some experiencing higher growth due to their broader market presence and scale.
- Goodness Growth's gross margin of 51% is within the typical range for cannabis companies, but it is important to monitor this metric as price compression occurs in maturing markets.
- The company's EBITDA of $6.8 million is a positive development, but it is still relatively low compared to larger MSOs, which have significantly higher EBITDA due to their scale and operational efficiencies.
- The legal challenges faced by Goodness Growth are not unique in the cannabis industry, as many companies have faced similar issues related to mergers and acquisitions, and regulatory compliance.
- The company's going concern issues are a significant concern and highlight the financial risks associated with operating in the cannabis industry, particularly for smaller companies with limited access to capital.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Interim CEO Josh Rosen | Josh Rosen | May 1, 2024 | Appointment from Interim to permanent CEO |
Legal Proceedings
- The company is involved in ongoing litigation with Verano Holdings, Inc. related to the termination of a share exchange agreement, seeking $869 million in damages.
- The company is also involved in various other regulatory issues, claims and lawsuits arising in the ordinary course of business.
Related Party Transactions
- As of March 31, 2024, there were $0 due to related parties.
Stakeholder Impact
- Shareholders face significant risk due to the company's going concern issues and potential dilution from capital raises.
- Employees may be affected by potential restructuring or asset sales.
- Customers may experience changes in product availability or service quality.
- Suppliers and creditors face increased risk due to the company's financial instability.
Next Steps
- The company will continue to pursue legal action against Verano.
- The company will implement a plan to mitigate going concern issues, which may include asset sales, debt restructuring, and capital raises.
- The company will continue to operate its cannabis cultivation, production, and dispensary facilities in Maryland, Minnesota, and New York.
- The company will seek to finalize a longer-term extension of its credit agreement with Chicago Atlantic Admin, LLC.
Key Dates
| Date | Description |
|---|---|
| November 23, 2004 | Goodness Growth Holdings, Inc. was incorporated under the Alberta Business Corporations Act. |
| October 23, 2017 | Original Lease Agreement date with IIP-NY 2 LLC. |
| January 31, 2022 | Goodness Growth entered into an Arrangement Agreement with Verano Holdings Corp. |
| October 13, 2022 | Goodness Growth received a notice of purported termination of the Arrangement Agreement from Verano. |
| October 21, 2022 | Goodness Growth commenced an action in the Supreme Court of British Columbia against Verano. |
| April 28, 2023 | The company closed on a new convertible debt facility. |
| July 31, 2023 | The company filed a requisition for adjournment of its application to compel Verano's compliance with document production. |
| March 5, 2024 | Sixth Amendment to Lease Agreement with IIP-NY 2 LLC. |
| March 11, 2024 | Seventh Amendment to Lease Agreement with IIP-NY 2 LLC. |
| March 31, 2024 | End of the reporting period for the quarterly results. |
| April 1, 2024 | Eighth amendment to lease and binding term sheet with ACE Ventures, LLC. |
| May 1, 2024 | Josh Rosen appointed as Chief Executive Officer and short-term extension of credit agreement. |
| May 2, 2024 | The company filed an application for summary determination in its litigation with Verano. |
| May 3, 2024 | Share data as of this date. |
| June 14, 2024 | Short-term extension of the maturity date on the term loan. |
| June 15, 2024 | Written notice of termination of lease needs to be provided by this date. |
Keywords
cannabis, revenue, EBITDA, legal, Maryland, adult-use, litigation, debt, going concern, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.